Tag: Orna Therapeutics
UBS Oncology Impact Fund Underlying Fund Portfolio Company Orna Therapeutics Announces...
UBS Oncology Impact Fund Underlying Fund Portfolio Company Orna Therapeutics Announces $3.75 Billion Funding to Develop Next Generation Vaccines
18th August 2022 | Hong Kong
UBS...